Debate: In the field of neurostimulation, what comes first, Published Research or Patents?

By SharpBrains | April 19, 2017

The Brain-Zap­ping Olympians (The Ringer): “Gain­ing jacked-up phys­i­cal pow­ers from frontal-lobe-elec­tri­­fy­ing head­gear sounds like a half-baked super­hero ori­gin sto­ry. It’s also a premise that ath­letes are buy­ing as real­i­ty. NBA play­ers and Olympians are wear­ing a brain-stim­u­la­­tion device called Halo Sport in an attempt to trans­form into champions.

Read More

Report: We are at the dawn of the Pervasive Neurotechnology age — witness the work by Nielsen, Microsoft, Posit Science, Jawbone, Accenture, NeuroSky, Medtronic, GE and more

By Zack Lynch | March 22, 2016

We are at the dawn of the per­va­sive neu­rotech­nol­o­gy age, when our every­day tech­nolo­gies inter­face with the user’s brain and mind, when devel­op­ers big and small har­ness the lat­est emo­tion­al, cog­ni­tive, sen­so­ry and behav­ioral tech­nolo­gies to cre­ate rad­i­cal­ly new expe­ri­ences to engage con­sumers and pro­fes­sion­als worldwide.

Read More

10 Non-invasive Neurotechnologies About to Transform Brain Enhancement and Brain Health

By Alvaro Fernandez | November 10, 2015

. 30,000+ sci­en­tists and pro­fes­sion­als gath­ered for the annu­al Soci­ety for Neu­ro­science con­fer­ence in Chica­go last month, prov­ing the grow­ing inter­est and activ­i­ties to bet­ter under­stand the inner work­ings of the human brain, and to dis­cov­er ways and tech­nolo­gies to enhance its health and per­for­mance. Now, which of all those ongo­ing efforts are clos­er to touch­ing our lives,…

Read More

The Neurotechnology Revolution: “The future is here; it’s just not evenly distributed yet”

By Potomac Institute for Policy Studies | October 7, 2015

. On Tues­day, Sep­tem­ber 29th, 2015, the Potomac Insti­tute for Pol­i­cy Stud­ies host­ed a sem­i­nar in col­lab­o­ra­tion with Sharp­Brains titled, “The Neu­rotech­nol­o­gy Rev­o­lu­tion: Mar­ket Trends & Impacts”. The sem­i­nar sought to ini­ti­ate a dis­cus­sion of the grow­ing trends in fund­ing and mar­ket devel­op­ment based on two recent­ly released reports on emerg­ing neu­rotech­nol­o­gy by Potomac Institute…

Read More

Neosync ranked #30 Holder of Pervasive Neurotech Intellectual Property*

By SharpBrains | August 19, 2015 |

Neo­sync is an ear­ly stage com­pa­ny devel­op­ing a new treat­ment  for major depres­sion based on Tran­scra­nial Mag­net­ic Stim­u­la­tion (TMS). The treatment–named NEST (Neo­sync EEG Syn­chro­nized TMS) and under­go­ing clin­i­cal trials–is based on the idea that depres­sion patients tend to have over­ly rhyth­mic brain activity, 

Read More